{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:51:31Z","timestamp":1794091891294,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Bundesgesundheitsministerium"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00406-019-01068-z","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T05:10:02Z","timestamp":1569647402000},"page":"403-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":244,"title":["Cannabis use and psychosis: a review of reviews"],"prefix":"10.1007","volume":"270","author":[{"given":"Alkomiet","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"von Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Maria","family":"Friemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Koethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Markus","family":"Leweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Strube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,28]]},"reference":[{"key":"1068_CR1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1017\/S0033291707002619","volume":"38","author":"E Barkus","year":"2008","unstructured":"Barkus E, Lewis S (2008) Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychol Med 38:1267\u20131276","journal-title":"Psychol Med"},{"key":"1068_CR2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","volume":"79","author":"SH Gage","year":"2016","unstructured":"Gage SH, Hickman M, Zammit S (2016) Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry 79:549\u2013556","journal-title":"Biol Psychiatry"},{"key":"1068_CR3","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","volume":"18","author":"R Martin-Santos","year":"2012","unstructured":"Martin-Santos R, Crippa JA, Batalla A et al (2012) Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des 18:4966\u20134979","journal-title":"Curr Pharm Des"},{"key":"1068_CR4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","volume":"15","author":"R Mechoulam","year":"2014","unstructured":"Mechoulam R, Hanus LO, Pertwee R et al (2014) Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat Rev Neurosci 15:757\u2013764","journal-title":"Nat Rev Neurosci"},{"key":"1068_CR5","first-page":"2","volume":"5","author":"SH Gage","year":"2013","unstructured":"Gage SH, Zammit S, Hickman M (2013) Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Med Rep 5:2","journal-title":"F1000 Med Rep"},{"key":"1068_CR6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/525S14a","volume":"525","author":"M Hill","year":"2015","unstructured":"Hill M (2015) Perspective: be clear about the real risks. Nature 525:S14","journal-title":"Nature"},{"key":"1068_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11920-015-0657-y","volume":"18","author":"C Ksir","year":"2016","unstructured":"Ksir C, Hart CL (2016) Cannabis and psychosis: a critical overview of the relationship. Curr Psychiatry Rep 18:12","journal-title":"Curr Psychiatry Rep"},{"key":"1068_CR8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1465-3362.2009.00132.x","volume":"29","author":"S Minozzi","year":"2010","unstructured":"Minozzi S, Davoli M, Bargagli AM et al (2010) An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 29:304\u2013317","journal-title":"Drug Alcohol Rev"},{"key":"1068_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","volume":"6","author":"M Di Forti","year":"2019","unstructured":"Di Forti M, Quattrone D, Freeman TP et al (2019) The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case\u2013control study. Lancet Psychiatry 6:427\u2013436","journal-title":"Lancet Psychiatry"},{"key":"1068_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","volume":"3","author":"T Schoeler","year":"2016","unstructured":"Schoeler T, Monk A, Sami MB et al (2016) Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis. Lancet Psychiatry 3:215\u2013225","journal-title":"Lancet Psychiatry"},{"key":"1068_CR11","first-page":"128","volume":"4","author":"JK Burns","year":"2013","unstructured":"Burns JK (2013) Pathways from cannabis to psychosis: a review of the evidence. Front Psychiatry 4:128","journal-title":"Front Psychiatry"},{"key":"1068_CR12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","volume":"259","author":"DC D\u2019souza","year":"2009","unstructured":"D\u2019souza DC, Sewell RA, Ranganathan M (2009) Cannabis and psychosis\/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 259:413\u2013431","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1068_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00406-002-0366-5","volume":"252","author":"G Bersani","year":"2002","unstructured":"Bersani G, Orlandi V, Kotzalidis GD et al (2002) Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatry Clin Neurosci 252:86\u201392","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1068_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamapsychiatry.2013.3726","volume":"71","author":"SM Hartz","year":"2014","unstructured":"Hartz SM, Pato CN, Medeiros H et al (2014) Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 71:248\u2013254","journal-title":"JAMA Psychiatry"},{"key":"1068_CR15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fpsyt.2014.00054","volume":"5","author":"R Radhakrishnan","year":"2014","unstructured":"Radhakrishnan R, Wilkinson ST, D\u2019souza DC (2014) Gone to pot\u2014a review of the association between cannabis and psychosis. Front Psychiatry 5:54","journal-title":"Front Psychiatry"},{"key":"1068_CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/mp.2015.35","volume":"20","author":"P Falkai","year":"2015","unstructured":"Falkai P, Rossner MJ, Schulze TG et al (2015) Kraepelin revisited: schizophrenia from degeneration to failed regeneration. Mol Psychiatry 20:671\u2013676","journal-title":"Mol Psychiatry"},{"key":"1068_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnins.2014.00019","volume":"8","author":"A Schmitt","year":"2014","unstructured":"Schmitt A, Malchow B, Hasan A et al (2014) The impact of environmental factors in severe psychiatric disorders. Front Neurosci 8:19","journal-title":"Front Neurosci"},{"key":"1068_CR18","doi-asserted-by":"crossref","first-page":"e1000326","DOI":"10.1371\/journal.pmed.1000326","volume":"7","author":"H Bastian","year":"2010","unstructured":"Bastian H, Glasziou P, Chalmers I (2010) Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med 7:e1000326","journal-title":"PLoS Med"},{"key":"1068_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2288-11-15","volume":"11","author":"V Smith","year":"2011","unstructured":"Smith V, Devane D, Begley CM et al (2011) Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 11:15","journal-title":"BMC Med Res Methodol"},{"key":"1068_CR20","volume-title":"Eine wissenschaftliche Bestandsaufnahme","author":"E Hoch","year":"2018","unstructured":"Hoch E, Friemel C, Schneider M (2018) Cannabis: Potenzial und Risiko. In: Hoch E, Friemel C, Schneider M (eds) Eine wissenschaftliche Bestandsaufnahme. Springer, Berlin"},{"key":"1068_CR21","unstructured":"\u00c4zq (2013) Institut f\u00fcr Medizinisches Wissensmanagement, \u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin. In: \u201cManual Systematische Literaturrecherche f\u00fcr die Erstellung von Leitlinien\u201d. 1. Auflage 2013. Verf\u00fcgbar: DCZ: \nhttp:\/\/www.cochrane.de\/de\/webliographie-litsuche\n\n; AWMF: \nhttp:\/\/www.awmf.org\/leitlinien\/awmf-regelwerk\/ll-entwicklung.html\n\n; \u00c4ZQ: \nhttp:\/\/www.aezq.de\/aezq\/publikationen\/kooperation"},{"key":"1068_CR22","volume-title":"Cochrane handbook for systematic reviews of interventions Version 5.1.0","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions Version 5.1.0. The Cochrane Collaboration, London"},{"key":"1068_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-019-00986-2","volume":"269","author":"W Hall","year":"2019","unstructured":"Hall W, Hoch E, Lorenzetti V (2019) Cannabis use and mental health: risks and benefits. Eur Arch Psychiatry Clin Neurosci 269:1\u20133","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1068_CR24","unstructured":"Awmf (2012) German Association of the Scientific Medical Societies (AWMF). AWMF-Regelwerk \u201cLeitlinien\u201d. 1. Auflage. In: Standing Guidelines Commission. AWMF guidance manual and rules for guideline development sEEvAahwaola-rh (ed)"},{"key":"1068_CR25","unstructured":"Ocebm (2011) Levels of evidence working group. In: Oxford Centre for Evidence-Based Medicine O (ed), 2nd edn"},{"key":"1068_CR26","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"1068_CR27","doi-asserted-by":"crossref","first-page":"e75132","DOI":"10.1371\/journal.pone.0075132","volume":"8","author":"K Hemming","year":"2013","unstructured":"Hemming K, Pinkney T, Futaba K et al (2013) A systematic review of systematic reviews and panoramic meta-analysis: staples versus sutures for surgical procedures. PLoS ONE 8:e75132","journal-title":"PLoS ONE"},{"key":"1068_CR28","volume-title":"Scottisch intercollegiate guidelines network 50 methodology checklist","author":"Sign","year":"2015","unstructured":"Sign (2015) Scottisch intercollegiate guidelines network 50 methodology checklist. Edinburgh, UK"},{"key":"1068_CR29","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.2174\/138161212802884672","volume":"18","author":"JK Burns","year":"2012","unstructured":"Burns JK (2012) Cannabis use and duration of untreated psychosis: a systematic review and meta-analysis. Curr Pharm Des 18:5093\u20135104","journal-title":"Curr Pharm Des"},{"key":"1068_CR30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","volume":"36","author":"J Koskinen","year":"2010","unstructured":"Koskinen J, Lohonen J, Koponen H et al (2010) Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36:1115\u20131130","journal-title":"Schizophr Bull"},{"key":"1068_CR31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291715002329","volume":"46","author":"T Kraan","year":"2016","unstructured":"Kraan T, Velthorst E, Koenders L et al (2016) Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. Psychol Med 46:673\u2013681","journal-title":"Psychol Med"},{"key":"1068_CR32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","volume":"68","author":"M Large","year":"2011","unstructured":"Large M, Sharma S, Compton MT et al (2011) Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 68:555\u2013561","journal-title":"Arch Gen Psychiatry"},{"key":"1068_CR33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1017\/S0033291712001626","volume":"43","author":"RJ Linscott","year":"2013","unstructured":"Linscott RJ, Van Os J (2013) An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med 43:1133\u20131149","journal-title":"Psychol Med"},{"key":"1068_CR34","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","volume":"42","author":"A Marconi","year":"2016","unstructured":"Marconi A, Di Forti M, Lewis CM et al (2016) Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull 42:1262\u20131269","journal-title":"Schizophr Bull"},{"key":"1068_CR35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319\u2013328","journal-title":"Lancet"},{"key":"1068_CR36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0004867415599846","volume":"50","author":"H Myles","year":"2016","unstructured":"Myles H, Myles N, Large M (2016) Cannabis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use. Aust N Z J Psychiatry 50:208\u2013219","journal-title":"Aust N Z J Psychiatry"},{"key":"1068_CR37","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.2174\/138161212802884816","volume":"18","author":"N Myles","year":"2012","unstructured":"Myles N, Newall H, Nielssen O et al (2012) The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Curr Pharm Des 18:5055\u20135069","journal-title":"Curr Pharm Des"},{"key":"1068_CR38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/00048670701579041","volume":"41","author":"S Potvin","year":"2007","unstructured":"Potvin S, Sepehry AA, Stip E (2007) Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Aust N Z J Psychiatry 41:792\u2013799","journal-title":"Aust N Z J Psychiatry"},{"key":"1068_CR39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S003329170500574X","volume":"36","author":"S Potvin","year":"2006","unstructured":"Potvin S, Sepehry AA, Stip E (2006) A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med 36:431\u2013440","journal-title":"Psychol Med"},{"key":"1068_CR40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/0004867414561526","volume":"49","author":"GE Sara","year":"2015","unstructured":"Sara GE, Large MM, Matheson SL et al (2015) Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation. Aust N Z J Psychiatry 49:106\u2013117","journal-title":"Aust N Z J Psychiatry"},{"key":"1068_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881105049040","volume":"19","author":"DM Semple","year":"2005","unstructured":"Semple DM, Mcintosh AM, Lawrie SM (2005) Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 19:187\u2013194","journal-title":"J Psychopharmacol"},{"key":"1068_CR42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.psychres.2014.05.008","volume":"219","author":"A Szoke","year":"2014","unstructured":"Szoke A, Galliot AM, Richard JR et al (2014) Association between cannabis use and schizotypal dimensions\u2014a meta-analysis of cross-sectional studies. Psychiatry Res 219:58\u201366","journal-title":"Psychiatry Res"},{"issue":"Suppl 1","key":"1068_CR43","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1521-0391.2012.00295.x","volume":"21","author":"A Baldacchino","year":"2012","unstructured":"Baldacchino A, Hughes Z, Kehoe M et al (2012) Cannabis psychosis: examining the evidence for a distinctive psychopathology in a systematic and narrative review. Am J Addict 21(Suppl 1):S88\u2013S98","journal-title":"Am J Addict"},{"key":"1068_CR44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/02791072.2007.10399871","volume":"39","author":"M Ben Amar","year":"2007","unstructured":"Ben Amar M, Potvin S (2007) Cannabis and psychosis: what is the link? J Psychoact Drugs 39:131\u2013142","journal-title":"J Psychoact Drugs"},{"key":"1068_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2014.04.026","volume":"156","author":"J Cookey","year":"2014","unstructured":"Cookey J, Bernier D, Tibbo PG (2014) White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies. Schizophr Res 156:137\u2013142","journal-title":"Schizophr Res"},{"issue":"Suppl 2","key":"1068_CR46","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.rbp.2012.07.003","volume":"34","author":"R Ferretjans","year":"2012","unstructured":"Ferretjans R, Moreira FA, Teixeira AL et al (2012) The endocannabinoid system and its role in schizophrenia: a systematic review of the literature. Revista brasileira de psiquiatria 34(Suppl 2):S163\u2013S177","journal-title":"Revista brasileira de psiquiatria"},{"key":"1068_CR47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fpsyt.2013.00136","volume":"4","author":"PA Geoffroy","year":"2013","unstructured":"Geoffroy PA, Etain B, Houenou J (2013) Gene \u00d7 environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging. Front Psychiatry 4:136","journal-title":"Front Psychiatry"},{"key":"1068_CR48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pscychresns.2013.07.012","volume":"214","author":"A James","year":"2013","unstructured":"James A, James C, Thwaites T (2013) The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry Res 214:181\u2013189","journal-title":"Psychiatry Res"},{"key":"1068_CR49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-012-0346-3","volume":"263","author":"B Malchow","year":"2013","unstructured":"Malchow B, Hasan A, Fusar-Poli P et al (2013) Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci 263:3\u201313","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1068_CR50","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.2174\/138161212802884861","volume":"18","author":"C Rapp","year":"2012","unstructured":"Rapp C, Bugra H, Riecher-Rossler A et al (2012) Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des 18:5070\u20135080","journal-title":"Curr Pharm Des"},{"key":"1068_CR51","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.2174\/138161212802884663","volume":"18","author":"G Serafini","year":"2012","unstructured":"Serafini G, Pompili M, Innamorati M et al (2012) Can cannabis increase the suicide risk in psychosis? A critical review. Curr Pharm Des 18:5165\u20135187","journal-title":"Curr Pharm Des"},{"key":"1068_CR52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/15734005113096660008","volume":"9","author":"U Vera","year":"2013","unstructured":"Vera U, Annarita T, Rocco P et al (2013) Cannabis and psychosis: a systematic review of genetic studies. Curr Psychiatry Rev 9:302\u2013315","journal-title":"Curr Psychiatry Rev"},{"key":"1068_CR53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1192\/bjp.bp.107.046375","volume":"193","author":"S Zammit","year":"2008","unstructured":"Zammit S, Moore TH, Lingford-Hughes A et al (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 193:357\u2013363","journal-title":"Br J Psychiatry"},{"key":"1068_CR54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1017\/S0033291716003172","volume":"47","author":"SH Gage","year":"2017","unstructured":"Gage SH, Jones HJ, Burgess S et al (2017) Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med 47:971\u2013980","journal-title":"Psychol Med"},{"key":"1068_CR55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","volume":"36","author":"RW Buchanan","year":"2010","unstructured":"Buchanan RW, Kreyenbuhl J, Kelly DL et al (2010) The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36:71\u201393","journal-title":"Schizophr Bull"},{"key":"1068_CR56","unstructured":"DGPPN (2019) S3-Leitlinie Schizophrenie 2019. Available online: \nhttps:\/\/www.awmf.org\/leitlinien\/detail\/ll\/038-009.html"},{"key":"1068_CR57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","volume":"50","author":"C Galletly","year":"2016","unstructured":"Galletly C, Castle D, Dark F et al (2016) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 50:410\u2013472","journal-title":"Aust N Z J Psychiatry"},{"key":"1068_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/15622975.2015.1009163","volume":"16","author":"A Hasan","year":"2015","unstructured":"Hasan A, Falkai P, Wobrock T et al (2015) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry 16:142\u2013170","journal-title":"World J Biol Psychiatry"},{"key":"1068_CR59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1192\/bjp.2018.1","volume":"212","author":"M Colizzi","year":"2018","unstructured":"Colizzi M, Murray R (2018) Cannabis and psychosis: what do we know and what should we do? Br J Psychiatry 212:195\u2013196","journal-title":"Br J Psychiatry"},{"key":"1068_CR60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2013.11.002","volume":"29","author":"T Ruther","year":"2014","unstructured":"Ruther T, Bobes J, De Hert M et al (2014) EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry 29:65\u201382","journal-title":"Eur Psychiatry"},{"key":"1068_CR61","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1017\/S0033291717000162","volume":"47","author":"SM Nielsen","year":"2017","unstructured":"Nielsen SM, Toftdahl NG, Nordentoft M et al (2017) Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study. Psychol Med 47:1668\u20131677","journal-title":"Psychol Med"},{"key":"1068_CR62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamapsychiatry.2018.0568","volume":"75","author":"C Hjorthoj","year":"2018","unstructured":"Hjorthoj C, Albert N, Nordentoft M (2018) Association of substance use disorders with conversion from schizotypal disorder to schizophrenia. JAMA Psychiatry 75:733\u2013739","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"1068_CR63","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41593-018-0206-1","volume":"21","author":"JA Pasman","year":"2018","unstructured":"Pasman JA, Verweij KJH, Gerring Z, Stringer S, Sanchez-Roige S, Treur JL, Abdellaoui A, Nivard MG, Baselmans BML, Ong J-S, Ip HF, van der Zee MD, Bartels M, Day FR, Fontanillas P, Elson SL, de Wit H, Davis LK, MacKillop J, Derringer JL, Branje SJT, Hartman CA, Heath AC, van Lier PAC, Madden PAF, Maegi R, Meeus W, Montgomery GW, Oldehinkel AJ, Pausova Z, Ramos-Quiroga JA, Paus T, Ribases M, Kaprio J, Boks MPM, Bell JT, Spector TD, Gelernter J, Boomsma DI, Martin NG, MacGregor S, Perry JRB, Palmer AA, Posthuma D, Munafo MR, Gillespie NA, Derks EM, Vink JM (2018) GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability. Nature Neuroscience 21(9):1161\u20131170","journal-title":"Nature Neuroscience"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-019-01068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-019-01068-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-019-01068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T23:33:43Z","timestamp":1601163223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-019-01068-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,28]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1007\/s00406-019-01068-z","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,28]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AH was an advisory board member of Janssen-Cliag, Otsuka, Lundbeck and Roche and he was a speaker for Janssen-Cliag, Otsuka and Lundbeck. FML is a shareholder of curantis UG (ltd.) and has received research grants from the German Federal Ministry of Education and Research and Acerus Pharmaceuticals. EH received research grants from the German Federal Ministry of Health and the European Monitoring Centre for Drugs and Drug Addiction. She receives fees for trainings and a treatment manual for cannabis use disorders. WS received speakers fees by Mag & More. All other authors did not report a conflict of interest. All other authors did not report any conflicts of interest related to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}